04:24 AM EDT, 03/20/2026 (MT Newswires) -- Eric Venker, President and Immunovant Chief Executive Officer, on March 17, 2026, sold 200,000 shares in Roivant Sciences ( ROIV ) for $5,648,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,647,546 common shares of the company, with 1,647,546 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1635088/000163508826000026/xslF345X05/wk-form4_1773959801.xml